Alpha Teknova Inc

Alpha Teknova Inc

TKNO · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

8.21USD-0.08 (-1.02%)

Price History

Full chart

Market Stats

Previous Close8.30
Open8.35
Day Range7.83 – 8.35
52-Week Range1.91 – 9.48
Volume416.67K
Market Cap500.91M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.31
Dividend Yield0.00%
Beta0.73
50-Day Avg6.67
200-Day Avg4.41

About

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Stephen Gunstream
  • Employees158
  • Headquarters2451 Bert Dr., Hollister, CA, United States, 95023, USA
  • Websitehttps://www.teknova.com

Leadership

  • Mr. Stephen GunstreamPresident, CEO & Director · b. 1980
  • Mr. Matthew C. LowellChief Financial Officer · b. 1971
  • Mr. Damon A. Terrill J.D.General Counsel, Chief Compliance Officer & Secretary · b. 1971
  • Ms. Jennifer HenrySenior Vice President of Marketing

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue20.09M31.30M36.89M41.42M36.68M37.74M40.52M
Growth (%)-+55.75%+17.88%+12.27%-11.43%+2.89%+7.35%
Cost of Revenue11.52M13.54M19.27M23.94M26.39M30.51M27.08M
Gross Profit8.57M17.75M17.62M17.48M10.30M7.23M13.44M
Gross Margin42.67%56.73%47.76%42.19%28.07%19.16%33.17%
Operating Expense10.43M13.09M29.63M67.14M45.86M33.38M30.42M
Operating Income-1.86M4.66M-12.01M-49.66M-35.56M-26.15M-16.98M
Operating Margin-9.24%14.90%-32.55%-119.89%-96.94%-69.27%-41.90%
EBITDA-233.00K6.71M-9.16M-25.69M-25.54M-19.57M-10.15M
EBITDA Margin-1.16%21.43%-24.84%-62.03%-69.62%-51.84%-25.05%
Net Income-1.30M3.57M-9.80M-47.47M-36.78M-26.75M-17.26M
Net Income Margin-6.49%11.41%-26.57%-114.60%-100.26%-70.86%-42.59%
R&D769.00K1.51M4.31M7.74M5.57M2.76M2.20M
R&D as % of Total Revenue3.83%4.82%11.69%18.68%15.18%7.31%5.42%
Interest Expense56.00K63.00K589.00K213.00K833.00K687.00K710.00K
Interest Expense % of Total Revenue0.28%0.20%1.60%0.51%2.27%1.82%1.75%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets58.51M62.91M166.51M152.26M128.59M118.77M103.58M
Total Liabilities45.60M10.51M23.31M52.38M38.55M36.38M34.81M
Total Equity12.91M52.41M143.20M99.89M90.04M82.39M68.78M
Cash4.14M3.31M87.52M42.24M28.48M3.71M5.91M
Total Debt45.00K-12.07M42.31M30.46M30.17M15.15M
Net Debt-4.10M-3.31M-75.65M74.00K1.97M26.46M9.23M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.17M2.50M-9.07M-27.40M-18.81M-12.39M-8.65M
Investing Cash Flow-8.16M-1.74M-17.52M-28.15M-7.74M-27.27M10.70M
Financing Cash Flow8.57M-1.60M110.79M10.27M12.80M14.89M151.00K
Capital Expenditure2.65M5.47M19.88M28.15M7.93M1.13M1.15M
Free Cash Flow-477.00K-2.96M-28.95M-55.55M-26.75M-13.52M-9.79M
Dividends Paid270.00K---252.00K--
FCF to OCF-21.96%-118.20%319.18%202.73%142.17%109.08%113.28%
Dividend Paid to FCF-56.60%----0.94%--

Earnings

Report DateMar 31, 2020Mar 31, 2021Jun 25, 2021Aug 11, 2021Nov 12, 2021Mar 15, 2022May 12, 2022Aug 10, 2022Nov 9, 2022Mar 15, 2023May 11, 2023Aug 10, 2023Nov 9, 2023Mar 11, 2024May 13, 2024Aug 13, 2024Nov 7, 2024Mar 4, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 26, 2026May 6, 2026Aug 5, 2026Nov 5, 2026
EPS Estimate0.000.00-0.04-0.18-0.12-0.17-0.21-0.25-0.29-0.34-0.28-0.28-0.27-0.24-0.25-0.16-0.11-0.12-0.11-0.10-0.09-0.09-0.09-0.08-0.06
EPS Actual0.08-0.34-0.03-0.45-0.10-0.11-0.20-0.22-0.22-0.47-0.31-0.18-0.26-0.21-0.20-0.13-0.15-0.11-0.09-0.07-0.08-0.09-0.08-0.06-
Surprise--25.00%-150.00%16.67%35.29%4.76%12.00%24.14%-38.24%-10.71%35.71%3.70%12.50%20.00%18.75%-36.36%8.33%18.18%29.72%11.11%0.00%11.11%25.00%-
Timing--After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap500.91M
Enterprise Value489.41M
Trailing P/E0.00
Forward P/E0.00
Price / Sales11.46
Price / Book7.66
EPS-0.31
Book Value1.17
Revenue (TTM)43.70M
Gross Profit (TTM)15.12M
EBITDA-8.97M
Profit Margin-38.37%
Operating Margin-23.72%
Return on Equity-24.19%
Return on Assets-9.28%
Shares Outstanding53.69M
Shares Float10.99M
Beta0.73
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 5 analystsTarget 9.00
  • Strong Buy
    3
  • Hold
    2

Ownership Breakdown

Institutions
87.34%
Insiders
9.31%
Retail / Other
3.35%

Top Institutional Holders

  • Roubaix Capital, LLC
    1.58M2.94%
  • Royce & Associates, LP
    1.07M1.99%
  • BlackRock Inc
    716.77K1.34%
  • Vanguard Capital Management, LLC
    441.88K0.82%
  • UBS Group AG
    325.16K0.61%
  • Conestoga Capital Advisors, LLC
    314.55K0.59%
  • Geode Capital Management, LLC
    307.87K0.57%
  • Bank of America Corp
    228.29K0.43%
  • State Street Corp
    155.09K0.29%
  • Squarepoint Ops LLC
    124.36K0.23%
  • The Goldman Sachs Group Inc
    118.44K0.22%
  • Morgan Stanley - Brokerage Accounts
    116.99K0.22%
  • Bank of New York Mellon Corp
    99.97K0.19%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.48M2.75%
  • Royce Micro-Cap Trust
    1.04M1.94%
  • Royce Micro-Cap Invmt
    467.23K0.87%
  • iShares Russell 2000 ETF
    301.26K0.56%
  • Royce Capital Micro-Cap Inv
    150.23K0.28%
  • Fidelity Small Cap Index
    122.92K0.23%
  • iShares Russell 2000 Growth ETF
    97.00K0.18%